LOS ANGELES, June 7, 2006 (PRIMEZONE) -- Universal Detection Technology (OTCBB:UDTT) (FWB:PO8), a developer of early-warning monitoring technologies designed to protect people from bio-terrorism and other infectious health threats, commented today on the creation of a new bio-terror panel by the National Counterproliferation Center (NCPC).
The purpose of the new panel is to bridge the gap between the scientific and intelligence communities on emerging bio-terrorism threats by providing information to federal agencies about developments in biotechnology. The NCPC was established in 2005 as part of the Office of the Director of National Intelligence.
"These are very sensitive times as far as the threat of terrorism with biological weapons is concerned. It is clear that authorities are not taking chances and are taking necessary measures to counter such attacks and to reduce possible casualties. As a private player in the field of bio-terror detection, we are happy to see such vigilance," said Amir Ettehadieh, UDTT's Director of Research and Development.
During testimony before the U.S. House of Representatives Committee on Homeland Security on May 4, 2006, Charles Allen, Chief Intelligence Officer of the Department of Homeland Security, stated that the intelligence community is becoming increasingly concerned about "lone wolf" terrorist cells with training in biosciences and the capability to create a crude but effective biological weapon. In a written statement he added, "We are especially concerned that small, loosely affiliated cells or individuals within the U.S. could conduct biological attacks. Such groups or individuals may not be affiliated with Al-Qaeda but merely subscribe to its ideology."
About Universal Detection Technology
Universal Detection Technology (UDTT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory (JPL) has developed a bio-terror 'smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://udtt.invrel.net or http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt; the ability of SSI to generate sales and increase visibility of the BSM-2000 based on its contacts and relationships in the United States; our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market; our ability to commercially produce our products on a profitable basis; commercial acceptance of our products; product price volatility; product demand; market competition and general economic conditions and; other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.